Configuring users of cholesterol lowering foods: A review of biomedical discourse

Social Science and Medicine

Volumn 71, Issue 9, 2010, Pages 1541-1547

  Weiner, K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Biomedical discourse; Cholesterol; Configuring users; Functional food; Health consumption; Health identity; Phytosterol; Review

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISPAGULA; PHYTOSTEROL;

FOOD CONSUMPTION; HOLISTIC APPROACH; LITERATURE REVIEW; MEDICINE; PUBLIC HEALTH; STEROL;

ARTICLE; CHOLESTEROL LOWERING FOOD; COST CONTROL; DRUG SAFETY; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD INTAKE; FOOD QUALITY; FOOD SAFETY; FUNCTIONAL FOOD; HEALTH CARE COST; HEALTH FOOD; HEALTH PROMOTION; HUMAN; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; NONHUMAN; OUTCOMES RESEARCH; PATIENT ATTITUDE;

ANTICHOLESTEREMIC AGENTS; BIOMEDICAL RESEARCH; CHOLESTEROL; FUNCTIONAL FOOD; HEALTH BEHAVIOR; HUMANS; HYPERCHOLESTEROLEMIA; PHYTOSTEROLS;

EID: 77957704038     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2010.06.048     Document Type: Article

References (77)

1. Akrich M. The de-scription of technical objects. Shaping technology/building society 1992, 205-224. MIT Press, Cambridge, Mass. W.E. Bijker, J. Law (Eds.).
2. American Dietetics Association Position of the American dietetic association: functional foods. Journal of the American Dietetic Association 2004, 104(5):814-826.
3. Anderson J.W. Diet first, then medication for hypercholesterolemia. Journal of the American Medical Association 2003, 290(4):531-533.
4. Anderson J.W. Ethical aspects of recommending lifestyle interventions to patients-reply. Journal of the American Medical Association 2003, 290(20):2660-2661.
5. Beck U. Risk society: Towards a new modernity 1992, Sage, London.
6. Bella L., Harris R., Chavez D., Fear J., Gill P. 'Everybody's talking at me': situating the client in the info(r)mediary work of the health professions. Mediating health information: The go-betweens in a changing socio-technical landscape 2008, 18-37. Palgrave Macmillan, Basingstoke. N. Wathen, S. Wyatt, R. Harris (Eds.).
7. Brendsel J., Green S.J. Regarding the potential perils of phytosterols. Atherosclerosis 2007, 192(1):227-229. [PubMed] author reply 230.
8. Brown N., Rappert B., Webster A. Introducing contested futures: from looking into the future to looking at the future. Contested futures: A sociology of contested techno-science 2000, 3-21. Ashgate, Farnham. N. Brown, B. Rappert, A. Webster (Eds.).
9. Brown N., Rip A., Van Lente H. Expectations in & about science and technology: a background paper for the 'expectations' workshop of 13-14 June 2003 Accessed 19.05.10. http://www.york.ac.uk/res/satsu/expectations/Utrecht%25202003/Background%2520paper%2520version%252014May03.pdf.
10. Burges D., Moreira T., Murtagh M. Little bottles and the promise of probiotics. Health 2009, 13(2):219-234.
11. Clarke A.E., Shim J.K., Mamo L., Fosket J.R., Fishman J.R. Biomedicalization: technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review 2003, 68(2):161-194.
12. Collins H.M., Evans R. The third wave of sciences studies: studies of expertise and experience. Social Studies of Science 2002, 32(2):235-296.
13. Commission of the European Communities Commission regulation (EC) No 608/2004 of 31 March 2004 concerning the labelling of foods and food ingredients with added phytosterol esters, phytostanol and/or phytostanol esters. Official Journal of the European Commission 2004, L097:44-45.
14. Conrad P. The shifting engines of medicalization. Journal of Health and Social Behavior 2005, 46(1):3-14.
15. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001, 285(19):2486-2497.
16. Fox N., Ward K. Health identities: from expert patient to resisting consumer. Health 2006, 10(4):461-479.
17. Fox N., Ward K. What are health identities and how may we study them?. Sociology of Health & Illness 2008, 30(7):1007-1021.
18. Gabe J., Calnan M. Health care and consumption. Health, medicine and society: Key theories, future agendas 2000, 255-273. Routledge, London. S. Williams, J. Gabe, M. Calnan (Eds.).
19. Giddens A. Modernity and self-identity: Self and society in the late modern age 1991, Polity Press, Cambridge.
20. Greco M. Psychosomatic subjects and the 'duty to be well': personal agency within medical rationality. Economy and Society 1993, 22:357-372.
21. Greener I. Patient choice in the NHS: the view from economic sociology. Social Theory and Health 2003, 1:72-89.
22. Heasman M., Mellentin J. The functional foods revolution. Healthy people, healthy profits? 2001, Earthscan Publications, London.
23. Hendriks H.F.J., Weststrate J.A., van Vliet T., Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. European Journal of Clinical Nutrition 1999, 53(4):319-327.
24. Henson S., Gregory S., Hamilton M., Walker A. Food choice and diet change within the family setting. The nation's diet: The social science of food choice 1998, 183-196. Longman, London. A. Murcott (Ed.).
25. Henwood F., Wyatts S., Hart A., Smith J. 'Ignorance is bliss sometimes': constraints on the emergence of the 'informed patient' in the changing landscapes of health information. Sociology of Health and Illness 2003, 25(6):589-607.
26. van Heyningen C. Cholesterol lowering margarine may not be useful in healthy fat modified diet. British Medical Journal 1999, 319(7203):186.
27. van Heyningen C. The debate on cholesterol lowering margarines. British Medical Journal 2000, Rapid Response online.
28. Holm L. Food health policies and ethics: lay perspectives on functional foods. Journal of Agricultural and Environmental Ethics 2003, 16:531-544.
29. Ikeda I., Sugano M. Inhibition of cholesterol absorption by plant sterols for mass intervention. Current Opinion in Lipidology 1998, 9(6):527-531.
30. Jacobson M.F., Silverglade B. Functional foods: health boon or quackery?. British Medical Journal 1999, 319(7204):205-206.
31. Jenkins D.J.A., Kendall C.W.C., Marchie A., Faulkner D.A., Wong J.M.W., de Souza R., et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and c-reactive protein. The Journal of the American Medical Association 2003, 290(4):502-510.
32. de Jong N., Klungel O.H., Verhagen H., Wolfs M.C.J., Ocke M.C., Leufkens H.G.M. Functional foods: the case for closer evaluation. British Medical Journal 2007, 334(7602):1037-1039.
33. de Jong N., Zuur A., Wolfs M.C.J., Wendel-Vos G.C.W., van Raaij J.M.A., Schuit A.J. Exposure and effectiveness of phytosterol/stanol-enriched margarines. European Journal of Clinical Nutrition 2007, 61(12):1407-1415.
34. Katan M.B. Functional foods. The Lancet 1999, 354(9181). 794-794.
35. Katan M.B., Grundy S.M., Jones P., Law M., Miettinen T., Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clinic Proceedings 2003, 78(8):965-978.
36. Kerr A. (Re)constructing genetic disease: the clinical continuum between cystic fibrosis and male infertility. Social Studies of Science 2000, 30(6):847-894.
37. Koteyko, N. Balancing the good, the bad and the better: a discursive perspective on probiotics and healthy eating. Health, in press.
38. Koteyko N. 'I am a very happy, lucky lady, and I am full of vitality!' Analysis of promotional strategies on the websites of probiotic yoghurt producers. Critical Discourse Studies 2009, 6(2):111-125.
39. Lambert H., Rose H. Disembodied knowledge? Making sense of medical science. Misunderstanding science? The public reconstruction of science and technology 1996, 65-83. Cambridge University Press, Cambridge. A. Irwin, B. Wynne (Eds.).
40. Lang T. Functional foods. British Medical Journal 2007, 334(7602):1015-1016.
41. Larkin M. Functional foods nibble away at serum cholesterol concentrations. The Lancet 2000, 355(9203):555.
42. Latour B. Where are the missing masses? The sociology of a few mundane artifacts. Shaping technology/building society: Studies in sociotechnical change 1992, 225-258. MIT Press, Cambridge, Mass. W.E. Bijker, J. Law (Eds.).
43. Law M. Plant sterol and stanol margarines and health. British Medical Journal 2000, 320(7238):861-864.
44. Lawrence M., Rayner M. Functional foods and health claims: a public health policy perspective. Public Health Nutrition 1998, 1(2):75-82.
45. Lehenkari J. On the borderline of food and drug: constructing credibility and markets for functional food product. Science As Culture 2003, 12(4):499-525.
46. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American heart association nutrition committee. Circulation 2006, 114(1):82-96.
47. Lichtenstien A., Deckelbaum R.J. Stanol/sterol ester-containing foods and blood cholesterol levels: a statement for healthcare professionals from the nutritional committee of the council on nutrition, physical activity, and metabolism of the AHA. Circulation 2001, 103:1177-1179.
48. Lupton D. The imperative of health: Public health and the regulated body 1995, Sage Publications, London.
49. Mayor S. Cholesterol lowering margarine launched in United Kingdom. British Medical Journal 1999, 318(7189):960.
50. McDonald R., Mead N., Cheraghi-Sohi S., Bower P., Whalley D., Roland M. Governing the ethical consumer: identity, choice and the primary care medical encounter. Sociology of Health & Illness 2007, 29(3):430-456.
51. Miettinen T.A., Puska P., Gylling H., Vanhanen H., Vartiainen E. Reduction of serum cholesterol by sitostanol-ester margarine in mildly hypercholesterolemic population. New England Journal of Medicine 1995, 333(20):1308-1312.
52. Murcott A. " It's a pleasure to cook for him" Food, mealtimes and gender in some South Wales households. The public and the private: Social patterns of gender relations 1983, 78-90. Heinemann, London. I.E. Gamarnikov, D. Morgan, J. Purvis, D. Taylorson (Eds.).
53. Nerlich B., Koteyko N. Balancing food risks and food benefits: the coverage of probiotics in the UK national press. Sociological Research Online 2008, 13(3):1. http://wwwsocresonline.org.uk/13/3/1.html.
54. Nettleton S., Burrows R. E-scaped medicine? Information, reflexivity and health. Critical Social Policy 2003, 23(2):165-185.
55. Niva M. 'All foods affect health': understandings of functional foods and healthy eating among health-oriented Finns. Appetite 2007, 48:384-393.
56. Niva M. Consumers and the conceptual and practical appropriation of functional foods 2008, National Consumer Research Centre, Helsinki.
57. Oudshoorn N. Clinical trials as a cultural niche in which to configure gender identities of users: the case of male contraceptive development. How users matter: The co-construction of users and technology 2005, 209-227. MIT Press, Cambridge, Mass. N. Oudshoorn, T. Pinch (Eds.).
58. Oudshoorn N., Pinch T. User-technology relationships: some recent developments. The handbook of science and technology studies 2008, 541-565. Massachusetts Institute of Technology, Cambridge, Massachusetts. E.J. Hackett, O. Amsterdamska, M. Lynch, J. Wajcman (Eds.).
59. Patch C.S., Tapsell L.C., Williams P.G., Gordon M. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence. Vascular Health & Risk Management 2006, 2(2):157-162.
60. Perisee D.M. Food fortification with plant sterol/stanol for hyperlipidemia: management in free-living populations. Journal of the American Dietetic Association 2005, 105(1):52-53.
61. Petersen A., Lupton D. The new public health: Health and self in the age of risk 1996, Sage, London.
62. Pound P., Britten N., Morgan M., Yardley L., Pope C., Daker-White G., et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Social Science & Medicine 2005, 61:133-155.
63. Prout A. Actor-network theory, technology and medical sociology: an illustrative analysis of the metered dose inhaler. Sociology of Health & Illness 1996, 18(2):198-219.
64. Rose N. Governing " advanced" liberal democracies. Foucault and political reason: Liberalism, neo-liberalism and rationalities of government 1996, 37-64. UCL Press, London. A. Barry, T. Osborne, N. Rose (Eds.).
65. Rose N. The politics of life itself: biomedicine, power, and subjectivity in the twenty-first century 2007, Princeton University Press, Princeton.
66. Simojoki M., Luoto R., Uutela A., Boice J.D., McLaughlin J.K., Puska P. Consistency of use of plant stanol ester margarine in Finland. Public Health Nutrition 2004, 7(01):63-68.
67. Thurnham D.I. Invited commentary: functional foods: cholesterol-lowering benefits of plant sterols. British Journal of Nutrition 1999, 82:255-256.
68. TNS Consumer research on the consumption of phytosterols: Prepared for the COI and the food standards agency 2006, TNS, London.
69. USA Food and Drug Administration Food labeling: health claims; plant sterol/stanol esters and coronary heart disease; interim final rule. Federal Register 2000, 65(175):54685-54739.
70. Uusitupa M., Hallikainen M. Efficacy of plant stanol ester margarine in subjects consuming healthy fat. British Medical Journal 1999, Rapid Response online.
71. Vainio H., Mutanen M. Functional foods - blurring the distinction between food and medicine. Scandinavian Journal of Work, Environment & Health 2000, 26(2):178-180.
72. Vuorio A.F., Gylling H., Turtola H., Kontula K., Ketonen P., Miettinen T.A. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation. Arteriosclerosis, Thrombosis and Vascular Biology 2000, 20(2):500-506.
73. Weststrate J.A., Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. European Journal of Clinical Nutrition 1998, 52(5):334-343.
74. Williams S.J., Calnan M. Perspectives on prevention: the views of general practitioners. Sociology of Health and Illness 1994, 16(3):372-393.
75. Wood D., Wray R., Poulter N., Williams B., Kirby M., Patel V., et al. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005, 91(Suppl. 5):v1-v52.
76. Woolgar S. Configuring the user: the case of usability trials. A sociology of monsters: Essays on power, technology and domination 1991, 57-99. Routledge, London. J. Law (Ed.).
77. Wyatt S. Non-users also matter: the construction of users and non-users of the Internet. How users matter: The co-construction of users and technology 2005, 67-79. MIT Press, Cambridge, Mass. N. Oudshoorn, T. Pinch (Eds.).